These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 30297972)

  • 21. Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
    Wasserstrum Y; Larrañaga-Moreira JM; Martinez-Veira C; Itelman E; Lotan D; Sabbag A; Kuperstein R; Peled Y; Freimark D; Barriales-Villa R; Arad M
    ESC Heart Fail; 2022 Aug; 9(4):2301-2312. PubMed ID: 35488723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline Characteristics of the VANISH Cohort.
    Axelsson Raja A; Shi L; Day SM; Russell M; Zahka K; Lever H; Colan SD; Margossian R; Hall EK; Becker J; Jefferies JL; Patel AR; Choudhury L; Murphy AM; Canter C; Bach R; Taylor M; Mestroni L; Wheeler MT; Benson L; Owens AT; Rossano J; Lin KY; Pahl E; Pereira AC; Bundgaard H; Lewis GD; Vargas JD; Cirino AL; McMurray JJV; MacRae CA; Solomon SD; Orav EJ; Braunwald E; Ho CY
    Circ Heart Fail; 2019 Dec; 12(12):e006231. PubMed ID: 31813281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
    Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management and outcomes of hypertrophic cardiomyopathy in young adults.
    Baron É; Karam N; Donal E; Puscas T; Mirabel M; Bacher A; Wahbi K; Mazzella JM; Jeunemaitre X; Reant P; Hagège A;
    Arch Cardiovasc Dis; 2021; 114(6-7):465-473. PubMed ID: 33744178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
    Lakdawala NK; Thune JJ; Colan SD; Cirino AL; Farrohi F; Rivero J; McDonough B; Sparks E; Orav EJ; Seidman JG; Seidman CE; Ho CY
    Circ Cardiovasc Genet; 2012 Oct; 5(5):503-10. PubMed ID: 22949430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy: results from multicenter registration in Japan.
    Fujita T; Fujino N; Anan R; Tei C; Kubo T; Doi Y; Kinugawa S; Tsutsui H; Kobayashi S; Yano M; Asakura M; Kitakaze M; Komuro I; Konno T; Hayashi K; Kawashiri MA; Ino H; Yamagishi M
    JACC Heart Fail; 2013 Dec; 1(6):459-66. PubMed ID: 24621997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural history of hypertrophic cardiomyopathy in a large Mediterranean cohort.
    Parcharidou D; Zegkos T; Ntelios D; Panagiotidis T; Katranas S; Siskos A; Meditskou S; Karvounis H; Efthimiadis G
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):428-434. PubMed ID: 32355065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients.
    Vasquez N; Ostrander BT; Lu DY; Ventoulis I; Haileselassie B; Goyal S; Greenland GV; Vakrou S; Olgin JE; Abraham TP; Abraham MR
    J Am Soc Echocardiogr; 2019 May; 32(5):593-603.e1. PubMed ID: 30904367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.
    Wang Y; Gao W; Han X; Jiang J; Sandler B; Li X; Zema C
    J Med Econ; 2023; 26(1):1495-1506. PubMed ID: 37902966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between left atrial myopathy and sarcomere mutation in patients with hypertrophic cardiomyopathy: insights into left atrial strain by MRI feature tracking.
    Wang J; Ma X; Zhao K; Yang S; Yang K; Yu S; Yin G; Dong Z; Song Y; Cui C; Li J; Zhao S; Chen X
    Eur Radiol; 2024 Feb; 34(2):1026-1036. PubMed ID: 37635167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry.
    Frommeyer G; Reinke F; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Eckardt L
    Clin Res Cardiol; 2020 Apr; 109(4):508-512. PubMed ID: 31367999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial Deformation Analysis in
    Höller V; Seebacher H; Zach D; Schwegel N; Ablasser K; Kolesnik E; Gollmer J; Waltl G; Rainer PP; Verheyen S; Zirlik A; Verheyen N
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yield of genetic testing in hypertrophic cardiomyopathy.
    Van Driest SL; Ommen SR; Tajik AJ; Gersh BJ; Ackerman MJ
    Mayo Clin Proc; 2005 Jun; 80(6):739-44. PubMed ID: 15945527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes of death and mortality in hypertrophic cardiomyopathy patients with implantable defibrillators in Sweden.
    Magnusson P; Gadler F; Liv P; Mörner S
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):478-84. PubMed ID: 26808417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.